Shikonin Sensitizes Wild‑type EGFR NSCLC Cells to Erlotinib and Gefitinib Therapy
Molecular Medicine Reports - Greece
doi 10.3892/mmr.2018.9347
Full Text
Open PDFAbstract
Available in full text
Date
August 3, 2018
Authors
Publisher
Spandidos Publications